Seven fatalities associated with ethylphenidate

P. D. Maskell, P. R. Smith, R. Cole, L. Hikin, S. R. Morley

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)

Abstract

Ethylphenidate is a stimulant novel psychoactive substance that is an analogue of the prescription drug methylphenidate (Ritalin®). Methylphenidate is used commonly for the treatment of attention deficit hyperactivity disorder. Due to its stimulant effects ethylphenidate is being abused. There is a single case report of a death associated with ethylphenidate in Germany, and a case series of 19 deaths in the East of Scotland, but otherwise, the contribution of ethylphenidate to death is poorly documented. We report the analytical results of 7 cases (between February 2013 and January 2015) in which ethylphenidate was detected and quantitated with a validated liquid chromatography tandem mass spectrometry method (LC-MS/MS). The individuals (all male) ranged in age from 23 to 49 years (median 25 years). The concentration of ethylphenidate in the cases ranged from 0.026mg/L to 2.18mg/L in unpreserved post-mortem femoral blood. Only one case had ethylphenidate present as a sole drug. All other cases had at least 2 other drug classes present (benzodiazepines, heroin, methadone antipsychotics, other new psychoactive compounds). Ethylphenidate toxicity was the sole contribution to the cause of death in one case. Hanging was the cause of death in 2 cases, with the other 4 cases being reported as having occurred due to mixed drug toxicity. These data will further help with the interpretation of post-mortem ethylphenidate levels.

Original languageEnglish
Pages (from-to)70-74
Number of pages5
JournalForensic Science International
Volume265
Early online date7 Jan 2016
DOIs
Publication statusPublished - 1 Aug 2016

Fingerprint

Dive into the research topics of 'Seven fatalities associated with ethylphenidate'. Together they form a unique fingerprint.

Cite this